Apr 24, 2021 Understanding tubulin modifications has remained a challenge till date because of unavailability of tools that can mark them in living cells. Researchers from inStem, Bangalore, India, in collaboration with Curie Institute, Orsay, France, funded by Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA), a bilateral organization supported by Department of Science & Technology (DST), Government of India and Government of France decided to overcome this shortcoming and developed the first tubulin nanobody – or sensor to study the dynamics of microtubule modifications in living cells and use this for identification of new cancer therapeutic drugs. This work has been recently published recently in the Journal of Cell Biology.